Is BDX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BDX. It does not provide personalized investment advice.

BDX (Becton, Dickinson and Co.) Stock Analysis - Financials

Becton, Dickinson and Co. (BDX) is a publicly traded Healthcare sector company. As of September 20, 2026, BDX trades at $179.72 with a market cap of $49.29B and a P/E ratio of 54.13. BDX moved -0.24% today. Year to date, BDX is -6.77%; over the trailing twelve months it is -3.94%. Its 52-week range spans $140.11 to $251.99. Analyst consensus is buy with an average price target of $193.30. Rallies surfaces BDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are BDX's key financials?

BDX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BDX recently traded at $179.72. Market cap is $49.29B. P/E ratio is 54.13. Revenue is $22.48B.

BDX Key Metrics

Key financial metrics for BDX
Metric	Value
Price	$179.72
Market Cap	$49.29B
P/E Ratio	54.13
EPS	$3.32
Dividend Yield	1.05%
52-Week High	$251.99
52-Week Low	$140.11
Volume	2.36M
Avg Volume	0
Revenue (TTM)	$22.48B
Net Income	$942.00M
Gross Margin	46.94%

BDX Analyst Consensus

10 analysts cover BDX: 0 strong buy, 5 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $193.30.

Common questions about BDX

What are BDX's key financials?: BDX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BDX recently traded at $179.72. Market cap is $49.29B. P/E ratio is 54.13. Revenue is $22.48B.
Is BDX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BDX. It does not provide personalized investment advice.